Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

HIV can cause unusual and severe skin problems that are hard to treat.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

A new skin-whitening agent using a peptide from wheat is safe and effective at reducing skin pigmentation.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

Combining electrodynamic microneedle with 5% minoxidil improves hair growth and reduces hair loss in Chinese men.

Patients with GATA2 deficiency show early skin symptoms that help diagnose the condition.

New physical methods like electrical currents, ultrasound, and microneedles show promise for improving drug delivery through the skin.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Minoxidil can cause deadly skin reaction; monitor patients closely.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.

A 3-year-old girl developed scurvy symptoms that improved with vitamin C but relapsed when supplementation stopped.

Nanoparticles can be used to deliver drugs to hair follicles, potentially improving treatments for conditions like acne and alopecia, and could also be used for vaccine delivery and gene therapy.

MSC-Exos can aid organ development and offer therapeutic benefits for various conditions.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

Immunization and throat bacteria may increase the risk of a hair loss condition called alopecia areata.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Biologics for severe asthma have known side effects, but some new risks need more study.

Traditional Chinese medicinal foods may help manage long-term post-COVID symptoms.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Long-COVID has diverse, long-term health impacts, especially in young people.

Lower LDL-c levels predict higher COVID-19 mortality.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

No cure exists for alopecia areata, and treatments are personalized.

Both induced and spontaneous AA lymphocytes can cause alopecia areata in mice.

Some plant extracts may treat livestock diseases, certain animal treatments are safe and effective, but more research on drug safety and resistance is needed.